Although this is still an experimental strategy that requires further research, it could be of great benefit in treating both DMD and BMD patients, leading to a sustained increase in the expression of the utrophin gene, regardless of the type of the mutation in the DMD gene [207]. This evidence concerns the gene DMD and Becker muscular dystrophy.